• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与 IBD 相关的肠道微生物组异质性和组装变化。

The gut microbiota heterogeneity and assembly changes associated with the IBD.

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Yunnan Institute of Digestive Disease, Kunming, Yunnan Province, China.

Computational Biology and Medical Lab, State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China.

出版信息

Sci Rep. 2019 Jan 24;9(1):440. doi: 10.1038/s41598-018-37143-z.

DOI:10.1038/s41598-018-37143-z
PMID:30679676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6345861/
Abstract

Inflammatory bowel disease (IBD) is an immunologically mediated disease and may be caused by abnormal immunological response to gut microbes. Although several studies on the ecological changes associated with IBD, such as community diversities, were reported, no previous studies have investigated the changes in the spatial heterogeneity and the mechanism of community assembly of the gut microbiota associated with IBD. In the present study, we first applied the Taylor's power law extensions to compare the community spatial heterogeneity between the gut microbial communities of the IBD patients and those of the healthy individuals. We found that the community spatial heterogeneity of gut microbiota in IBD patients is slightly lower than in the healthy individuals. This finding suggests that IBD may lower the spatial heterogeneity of gut microbiota, possibly via lowering the abundance of dominant species. We further applied the neutral theory of biodiversity to comparatively investigate the community assembly and diversity maintenance of the gut microbiota with and without IBD, and our application suggested that deterministic factors such as host immunity should be dominant forces shaping gut microbiota assembly, and diseases such as IBD may not be strong enough to change the trend set by the deterministic host factors.

摘要

炎症性肠病(IBD)是一种免疫介导的疾病,可能是由对肠道微生物的异常免疫反应引起的。尽管已经有几项关于与 IBD 相关的生态变化的研究,如群落多样性,但以前没有研究调查过与 IBD 相关的肠道微生物群落的空间异质性和群落组装机制的变化。在本研究中,我们首先应用泰勒幂律扩展来比较 IBD 患者和健康个体肠道微生物群落的社区空间异质性。我们发现 IBD 患者肠道微生物群落的社区空间异质性略低于健康个体。这一发现表明,IBD 可能会降低肠道微生物群落的空间异质性,可能是通过降低优势物种的丰度。我们进一步应用生物多样性中性理论来比较性地研究有无 IBD 时肠道微生物群落的组装和多样性维持,我们的应用表明,宿主免疫等决定性因素应该是塑造肠道微生物群落组装的主要力量,而像 IBD 这样的疾病可能不足以改变由决定性宿主因素设定的趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de11/6345861/3e0c3255de23/41598_2018_37143_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de11/6345861/01caa92e4a64/41598_2018_37143_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de11/6345861/e504a57c88b1/41598_2018_37143_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de11/6345861/62358024a20d/41598_2018_37143_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de11/6345861/3e0c3255de23/41598_2018_37143_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de11/6345861/01caa92e4a64/41598_2018_37143_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de11/6345861/e504a57c88b1/41598_2018_37143_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de11/6345861/62358024a20d/41598_2018_37143_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de11/6345861/3e0c3255de23/41598_2018_37143_Fig4_HTML.jpg

相似文献

1
The gut microbiota heterogeneity and assembly changes associated with the IBD.与 IBD 相关的肠道微生物组异质性和组装变化。
Sci Rep. 2019 Jan 24;9(1):440. doi: 10.1038/s41598-018-37143-z.
2
Gut microbiota and IBD: causation or correlation?肠道微生物群与炎症性肠病:因果关系还是相关性?
Nat Rev Gastroenterol Hepatol. 2017 Oct;14(10):573-584. doi: 10.1038/nrgastro.2017.88. Epub 2017 Jul 19.
3
Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice.IBD 母亲所生婴儿的肠道微生物组发生改变,这种改变将适应性免疫系统的异常传递给无菌小鼠。
Gut. 2020 Jan;69(1):42-51. doi: 10.1136/gutjnl-2018-317855. Epub 2019 Apr 29.
4
Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers.炎症性肠病中唾液微生物群失调及其与口腔免疫生物标志物的关联。
DNA Res. 2014 Feb;21(1):15-25. doi: 10.1093/dnares/dst037. Epub 2013 Sep 7.
5
Mouse IgA modulates human gut microbiota with inflammatory bowel disease patients.鼠 IgA 可调节炎症性肠病患者的人肠道微生物群。
J Gastroenterol. 2024 Sep;59(9):812-824. doi: 10.1007/s00535-024-02121-y. Epub 2024 Jun 14.
6
Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.肠道微生物群在炎症性肠病发病机制中的作用的最新进展。
J Dig Dis. 2013 Oct;14(10):513-7. doi: 10.1111/1751-2980.12087.
7
Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.粪便微生物组研究揭示了脊柱关节炎中的特定失调。
Ann Rheum Dis. 2017 Sep;76(9):1614-1622. doi: 10.1136/annrheumdis-2016-211064. Epub 2017 Jun 12.
8
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.宿主遗传学与肠道微生物群在炎症性肠病发病及临床表现中的相互作用
Gut. 2018 Jan;67(1):108-119. doi: 10.1136/gutjnl-2016-312135. Epub 2016 Oct 8.
9
Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.免疫缺陷导致的肠道微生物群失调与结肠炎疾病外显率之间的相互关系。
Immunology. 2015 Nov;146(3):359-68. doi: 10.1111/imm.12511. Epub 2015 Sep 7.
10
Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.炎症性肠病与慢性阻塞性肺疾病的关联。
Front Immunol. 2020 Sep 11;11:2144. doi: 10.3389/fimmu.2020.02144. eCollection 2020.

引用本文的文献

1
Recent advances in the application of microbiota transplantation in chickens.鸡肠道微生物群移植应用的最新进展。
J Anim Sci Biotechnol. 2025 Jun 27;16(1):91. doi: 10.1186/s40104-025-01233-6.
2
Disrupting the balance: how acne duration impacts skin microbiota assembly processes.打破平衡:痤疮持续时间如何影响皮肤微生物群的组装过程。
Microbiol Spectr. 2025 Apr;13(4):e0260324. doi: 10.1128/spectrum.02603-24. Epub 2025 Feb 24.
3
The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases.肠道微生物组推动炎症性肠病的精准医学和诊断进展。

本文引用的文献

1
Gut microbiota and IBD: causation or correlation?肠道微生物群与炎症性肠病:因果关系还是相关性?
Nat Rev Gastroenterol Hepatol. 2017 Oct;14(10):573-584. doi: 10.1038/nrgastro.2017.88. Epub 2017 Jul 19.
2
Dynamics of the human gut microbiome in inflammatory bowel disease.炎症性肠病患者的肠道微生物组动态变化。
Nat Microbiol. 2017 Feb 13;2:17004. doi: 10.1038/nmicrobiol.2017.4.
3
The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis.肠道微生物群与炎症性肠病活动之间的关联:一项系统评价和荟萃分析。
Int J Mol Sci. 2024 Oct 19;25(20):11259. doi: 10.3390/ijms252011259.
4
Plant-derived vesicle-like nanoparticles: A new tool for inflammatory bowel disease and colitis-associated cancer treatment.植物来源的囊泡样纳米颗粒:治疗炎症性肠病和结肠炎相关癌症的新工具。
Mol Ther. 2024 Apr 3;32(4):890-909. doi: 10.1016/j.ymthe.2024.02.021. Epub 2024 Feb 18.
5
Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future.肠道微生物群和 miRNA 在炎症性肠病中的作用:一项关于发现和未来展望的叙述性综述。
Int J Mol Sci. 2023 Apr 13;24(8):7176. doi: 10.3390/ijms24087176.
6
Medicinal plant-based drug delivery system for inflammatory bowel disease.用于炎症性肠病的基于药用植物的药物递送系统。
Front Pharmacol. 2023 Mar 23;14:1158945. doi: 10.3389/fphar.2023.1158945. eCollection 2023.
7
Dynamic Population of Gut Microbiota as an Indicator of Inflammatory Bowel Disease.肠道微生物群的动态变化作为炎症性肠病的指标。
Iran Biomed J. 2022 Sep 1;26(5):350-6. doi: 10.52547/ibj.3772.
8
Gut Microbiota Associated with Clinical Relapse in Patients with Quiescent Ulcerative Colitis.与静止期溃疡性结肠炎患者临床复发相关的肠道微生物群
Microorganisms. 2022 May 18;10(5):1044. doi: 10.3390/microorganisms10051044.
9
Microbiota and HPV: The role of viral infection on vaginal microbiota.微生物群与 HPV:病毒感染对阴道微生物群的作用。
J Med Virol. 2022 Sep;94(9):4478-4484. doi: 10.1002/jmv.27837. Epub 2022 May 16.
10
Plant-Derived Exosomes as a Drug-Delivery Approach for the Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer.植物来源的外泌体作为治疗炎症性肠病和结肠炎相关癌症的药物递送方法。
Pharmaceutics. 2022 Apr 8;14(4):822. doi: 10.3390/pharmaceutics14040822.
Scand J Gastroenterol. 2016 Dec;51(12):1407-1415. doi: 10.1080/00365521.2016.1216587. Epub 2016 Aug 9.
4
Testing the Neutral Theory of Biodiversity with Human Microbiome Datasets.用人类微生物组数据集检验生物多样性的中性理论。
Sci Rep. 2016 Aug 16;6:31448. doi: 10.1038/srep31448.
5
Temporal Stability of the Human Skin Microbiome.人类皮肤微生物群的时间稳定性
Cell. 2016 May 5;165(4):854-66. doi: 10.1016/j.cell.2016.04.008.
6
Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.肠道微生物群失调作为炎症性肠病和肠易激综合征在儿童期至成年期过渡阶段的风险因素和发病前因素。
Inflamm Bowel Dis. 2016 Feb;22(2):487-504. doi: 10.1097/MIB.0000000000000602.
7
Power law analysis of the human microbiome.人类微生物组的幂律分析。
Mol Ecol. 2015 Nov;24(21):5428-45. doi: 10.1111/mec.13394.
8
Backbones of evolutionary history test biodiversity theory for microbes.进化历史的主干检验微生物的生物多样性理论。
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8356-61. doi: 10.1073/pnas.1419341112. Epub 2015 Jun 23.
9
Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD.人类肠道微生物群的偏差:一种用于确定肠易激综合征或炎症性肠病患者菌群失调的新型诊断测试。
Aliment Pharmacol Ther. 2015 Jul;42(1):71-83. doi: 10.1111/apt.13236. Epub 2015 May 14.
10
Community assembly of a euryhaline fish microbiome during salinity acclimation.广盐性鱼类微生物群落在盐度适应过程中的群落组装
Mol Ecol. 2015 May;24(10):2537-50. doi: 10.1111/mec.13177. Epub 2015 Apr 20.